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R E V I E W A R T I C L E
Human Paragonimiasis in North America
following Ingestion of Raw Crayfish
Michael A. Lane,1 Mary C. Barsanti,1 Carlos A. Santos,1 Michael Yeung,2 Sam J. Lubner,2 and Gary J. Weil1
1Infectious Diseases Division and 2Department of Internal Medicine, Washington University, St. Louis, Missouri
Paragonimiasis (human infections with the lung fluke Paragonimus westermani) is an important public health
problem in parts of Southeast Asia and China. Paragonamiasis has rarely been reported from North America
as a zoonosis caused by Paragonimus kellicotti. Paragonimus species have complex life cycles that require 2
intermediate hosts, namely, snails and crustaceans (ie, crabs or crayfish). Humans acquire P. kellicotti when
they consume infected raw crayfish. Humans with paragonimiasis usually present with fever and cough, which,
together with the presentation of hemoptysis, can be misdiagnosed as tuberculosis. Only 7 autochthonous
cases of paragonimiasis have been previously reported from North America. Our study describes 3 patients
with proven or probable paragonimiasis with unusual clinical features who were seen at a single medical
center during an 18-month period. These patients acquired their infections after consuming raw crayfish from
rivers in Missouri. It is likely that other patients with paragonimiasis have been misdiagnosed and improperly
treated. Physicians should consider the possibility that patients who present with cough, fever, hemoptysis,
and eosinophilia may have paragonimiasis.
Paragonimiasis is an infection caused by trematode par-
asites of the genus Paragonimus. Patients with para-
gonimiasis usually present with signs and symptoms in
the lower respiratory tract. At least 9 species have been
identified that cause infections in humans [1]. Para-
gonimus westermani is an important pathogen in South-
east Asia and China [2]. Paragonimiasis is uncommon
among North Americans who have not traveled or lived
in endemic areas in the far east. Most North American
cases of paragonimiasis are caused by Paragonimus kel-
licotti [3]. P. kellicotti infections in bobcats [4], raccoons
[5], gray foxes [6], red foxes [7], skunks [7], mink [7,
8], coyotes [7], cats, and dogs have been reported. The
purpose of our study is to describe 3 recent North
American cases of paragonimiasis at a large teaching
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hospital and to review the clinical features of paragon-
imiasis in North America.
CLINICAL CASES
Patient 1
Patient 1 was a previously healthy 26-year-old female
who presented to her local hospital with a 2-week his-
tory of fatigue, malaise, cough, fevers, night sweats, and
vomiting. She was admitted to her local hospital and
given a working diagnosis of community-acquired
pneumonia. She was treated with levofloxacin and dis-
charged from the hospital.
She returned to the hospital when her symptoms
persisted. Laboratory studies at that time showed a pe-
ripheral eosinophil count of 2000 cells/mm3 (eosinophil
percentage, 20%). She underwent bronchoscopy with
transbronchial biopsy. The biopsy demonstrated an eo-
sinophilic inflammatory infiltrate. Bronchoalveolar lav-
age (BAL) also demonstrated eosinophilia. Routine BAL
culture, mycobacterial culture, and fungal culture results
were negative. Methylprednisolone therapy was initiated
for a presumed diagnosis of eosinophilic pneumonia.
The patient’s symptoms improved with the use of
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Figure 1. Computed tomography scan of the chest of patient 1 showing
a focal consolidation in the superior segment of the left lower lobe
(arrowhead) and a left pleural effusion.
malaise returned when use of steroids was tapered. She also
developed a 0.5-cm nodular lesion inferior to her left lower
lip. A needle biopsy demonstrated an inflammatory infiltrate
with conspicuous eosinophils. The lesion grew in size to 1.5
cm and migrated to her left cheek.
She was referred to our tertiary care hospital for further
evaluation. Physical examination was notable for detecting a 2-
cm firm, nontender mobile mass on the left cheek. Breath
sounds were diminished at the left base. The remainder of her
physical examination was normal. Her white blood cell count
was 6200 cells/mm3, with an absolute eospinophil count of 800
cells/mm3 (eosinophil percentage, 13.7%). A computed to-
mography (CT) scan (figure 1) revealed a left pleural effusion
and a focal opacity at the apex of the left lower lung lobe.
Serum samples tested negative for Rickettsia, Ehrlichia, and
Strongyloides species as well as for Epstein-Barr virus, herpes
simplex virus, cytomegalovirus, and human immunodeficien-
cy virus. Patient 1 was unable to provide a sputum specimen
despite repeated attempts at sputum induction.
Upon further questioning, the patient revealed that she had
been on a “float trip” on a tributary of the Meramec River in
southeastern Missouri ∼4 weeks before the onset of her symp-
toms. She also stated that she had eaten 2 uncooked crawfish
from the river while intoxicated. Two weeks after returning
from the float trip, she developed a self-limited diarrheal illness.
She later experienced fatigue, malaise, cough, fevers, night
sweats, and vomiting. An enzyme-linked immunoabsorbent as-
say (ELISA; developed by Parasitic Disease Consultants) was
positive for Paragonimus species at 1:32. The patient received
a diagnosis of paragonimiasis and was treated with praziquantel
75 mg/kg in 3 divided doses for 2 days. Her systemic symptoms
resolved within 48 h of initiating therapy, and the left cheek
mass resolved within 7 days of treatment. Treatment with meth-
ylprednisolone was tapered and discontinued. One month after
treatment, the patient denied having symptoms of fever, night
sweats, cough, or malaise. A complete blood cell count at that
time revealed a total white blood cell count of 5700 cells/mm3
with a normal eosinophil count.
Patient 2
Patient 2 was a previously healthy 32-year-old male who pre-
sented with a 3-month history of recurrent fevers (with tem-
peratures as high as 39.5C [103F]), myalgias, arthralgias, gen-
eralized malaise, and cough producing minimal brownish
sputum. The patient also noticed an indurated tender nodule
on the dorsal surface of his left fourth distal interphalangeal
joint. His primary care physician ordered a chest radiograph
that showed hazy bilateral upper lobe infiltrates and small bi-
lateral pleural effusions. He was treated with levofloxacin for
7 days for presumed community-acquired pneumonia.
The patient’s symptoms persisted while on levofloxacin. In
addition, he developed diffuse headaches and blurred vision.
He described the headaches as “sharp” and “splitting.” In ad-
dition, he also reported abnormal vision with intermittent blind
spots and floaters. He was admitted to a community hospital
where cerebral spinal fluid analysis and CT scan of the head
were normal. A complete blood cell count revealed a white
blood cell count of 12,000 cells/mm3 with an absolute eosin-
ophil count of 3600 cells/mm3 (eosinophil percentage, 30%).
The findings of basic chemistry and liver function tests were
all normal. All blood and urine culture results were negative.
Bronchoscopy was performed, and BAL revealed eosinophilia.
He was given a diagnosis of eosinophilic pneumonia and treated
with prednisone 60 mg daily. Steroid therapy initially improved
his symptoms; however, his symptoms returned when his ste-
roid dose was decreased.
The patient was referred to our hospital for further evalu-
ation of his symptoms. His physical examination was significant
for the detection an indurated, tender nodule on the volar
aspect of his left fourth distal interphalangeal joint. The patient
reported that the nodule was migratory. The findings of a neu-
rologic examination were normal. A complete blood cell count
showed a white blood cell count of 10,100 cells/mm3 with an
absolute eosinophil count of 3000 cells/mm3 (eosinophil per-
centage, 30%). Serum samples tested negative for Rickettsia,
Ehrlichia, and Strongyloides species as well as for Epstein-Barr
virus, herpes simplex virus, cytomegalovirus, and human im-
munodeficiency virus. A chest radiograph showed bilateral up-
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Figure 3. Computed tomography scan of the chest of patient 3 showing
a right apical mass.
Figure 2. Magnetic resonance imaging (MRI) of the brain of patient 2 showing a 7  4  2 mm lesion in the right occipital lobe (arrowhead). A, T1-
weighted brain MRI. B, Postcontrast enhancement of right occipital lobe lesion.
brain (figure 2) showed an enhancing lesion in the right oc-
cipital lobe.
Upon further questioning, the patient reported eating raw
crayfish while intoxicated during a float trip on the Current
River in southern Missouri ∼3 weeks before the onset of his
symptoms. An ELISA performed at the Centers for Disease
Control and Prevention was positive for Paragonimus species.
The patient was treated with a 3-day course of praziquantel 75
mg/kg in 3 divided doses for pulmonary, cutaneous, and prob-
able cerebral paragonimiasis. His symptoms resolved within 3
days of starting therapy. After 1 month of follow-up, the patient
was free of symptoms. A complete blood cell count showed
resolution of his leukocytosis and eosinophilia.
Patient 3
Patient 3 was a previously healthy 31-year-old male who pre-
sented with a 2-week history of fevers and pharyngitis. He was
seen at an urgent care facility where a monospot test and a
rapid streptococcal antigen test were performed, both of which
were negative. After several days of continued symptoms, the
patient was evaluated at his local emergency department. The
findings of a lumbar puncture, a blood culture, and a chest
radiograph were within normal limits. The patient was dis-
charged from the emergency department with a 7-day course
of doxycycline for a presumed tick-related infection.
The patient completed the course of doxycycline but con-
tinued to have fevers. In addition, he developed chills, rigors,
night sweats, headaches, and shortness of breath. The patient
was prescribed cefuroxime, which did not alter his symptoms.
The patient had continued fevers and worsening shortness of
breath. He also reported diffuse chest pain and weight loss. He
denied having abdominal pain, nausea, vomiting, skin changes,
arthritis or arthralgias.
The patient presented to our tertiary care hospital with con-
tinued fever, chills, shortness of breath, and cough. A physical
examination revealed a temperature of 39.2C and diminished
breath sounds at the right lung base. The remainder of the
findings of the examination were within normal limits. Lab-
oratory studies revealed a white blood cell count of 11,300 cells/
mm3 with an absolute eosinophil count of 2300 cells/mm3 (eo-
sinophil percentage, 20%). A chest radiograph revealed a right-
sided pleural effusion. A CT scan of the chest showed a right
pleural effusion and an apical mass in the right lung (figure
3). A thoracentesis was performed. Pleural fluid analysis showed
5.6 g/dL of protein, 2074 IU/L of lactate dehydrogenase, and
!30 mg/dL of glucose. The total cell count in the pleural fluid
was 44,650 cells/mL, with a nucleated cell count of 14,650 cells/
mL (18% neutrophils, 8% lymphocytes, 6% monocytes, and
68% eosinophils). Gram stain of pleural fluid specimen showed
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results for bacteria, fungus, and acid-fast bacilli were negative.
A pleural biopsy revealed abundant histiocytes with poorly
formed granulomas. Patient 3 had a serum protein level of 7.2
g/dL and a lactate dehydrogenase level of 157 IU/L.
The patient reported that he had visited Cancun, Mexico, 6
weeks before the onset of his symptoms. He spent 5 days at a
resort where he ate food prepared at the resort and drank only
bottled water. The patient was initially treated with doxycycline
and primaquine without improvement in his symptoms. Fur-
ther questioning revealed that the patient had gone on a float
trip on the Jacks Fork and Current Rivers in southeastern Mis-
souri 1 week after his return from Cancun and that he had
consumed 2 raw crayfish while intoxicated during this outing.
His symptoms began ∼4 weeks after consuming the raw cray-
fish. Treatment with doxycycline and primaquine was discontin-
ued, and the patient was treated with praziquantel 75 mg/kg in
3 divided doses for 2 days. The patient defervesced, and his
symptoms resolved promptly after treatment with praziquantel.
Serum samples obtained during his hospitalization and 2
months after treatment tested negative for antibodies to P. wes-
termanii using an ELISA performed at the Centers for Disease
Control and Prevention. Another chest radiograph 3 weeks after
hospital discharge showed resolution of the right apical infil-
trate. All symptoms and the eosinophilia had resolved by the
time of his 2-month follow-up visit.
DISCUSSION
In 1894, Drs. Ward and Kellicott described Paragonimus par-
asites in lung tissue from a dog in Ohio and a cat in Michigan
[3, 9, 10]. Ward distinguished North American Paragonimus
worms from those found in Asia, on the basis of differences
in morphology, and named the new species P. kellicotti. Sub-
sequent investigators have confirmed these morphological dif-
ferences [11, 12]. While molecular phylogenetic analyses have
been performed on Paragonimus species endemic to Asia [13,
14], this has not been done yet for Paragonimus species from
North America.
Paragonimus lung flukes have a complex life cycle that re-
quire 2 intermediate hosts and 1 definitive host. Eggs excreted
in stool hatch in water to become ciliated miracidia that invade
the soft tissue of snails, the first intermediate host [15]. The
parasite develops in snails to become cercariae, which leave the
snail and invade the second intermediate host. The second
intermediate host for P. kellicotti are crayfish of the genera
Cambarus and Orconectes. The cercariae encyst in muscle and
become metacercariae. When ingested by the appropriate de-
finitive host, the metacercariae excyst in the duodenum and
migrate to the lungs, where they mature into adult worms that
produce eggs. P. kellicotti has a wide host range that includes
carnivores (such as mink, muskrat, and opossum) and domestic
animals (such as cats and dogs). Humans are accidental hosts.
Human infections with the Paragonimus species have been
identified in many parts of the world, but they are most com-
mon in eastern Asia. It is estimated that 292.8 million people
worldwide are at risk for infection with Paragonimus species,
with 195 million people at risk in China [16]. Seroprevalence
in China ranges from 1.9% in Anhui and Liaoning Provinces
to 33.7% in Jilin Province [2]. Paragonimiasis in humans is
uncommon in North America, with only 7 cases previously
described in patients who acquired the infection without trav-
eling abroad or eating imported food items (table 1). Our pa-
tients were infected by eating uncooked crayfish from rivers
in Missouri.
Humans acquire Paragonimus infections when they con-
sume metacercariae from uncooked shellfish, such as crabs
and crayfish. People in parts of eastern Asia commonly eat raw
or alcohol-cured crustaceans [24], and this explains the high
incidence of paragonimiasis in that region. In contrast to Asia,
consumption of raw crustaceans is uncommon in North Amer-
ica. It is very likely that alcohol played a role in our cases by
relaxing normal dietary inhibitions. The distribution of P. kel-
licotti in North America has not been mapped in detail, but
the parasite is known to be widely distributed in the midwest
region of the United States. Most previously reported cases
have been from this region.
P. westermani infections can cause a variety of clinical symp-
toms. Early infections are often asymptomatic, and it is likely
that some infected persons never present with clinical disease.
Pulmonary symptoms typically present months after infection
(range, 1–27 months; mean, 6 months) [25]. Cough and he-
moptysis are common (seen in 60%–00% of patients) [26–29]
Fever is also common (11%–67% of patients) [26–28]. Given
this constellation of symptoms, it is not surprising that para-
gonimiasis is often confused with tuberculosis [26–28]. Cough,
fever, and hemoptysis are also common in patients with P.
kellicotti infection (table 1). Paragonimus flukes sometimes mi-
grate to ectopic locations, including the central nervous system
(CNS) [30]. Patients with CNS involvement often report head-
aches as the presenting symptom. Our patient 2 experienced
headaches and had abnormal findings on magnetic resonance
imaging consistent with paragonimiasis of the CNS. To our
knowledge, this is the first described case of P. kellicotti infection
with probable CNS involvement. Seizures occur in 40% of pa-
tients with CNS involvement, and many patients (55%) have
impaired vision and/or visual field deficits. CNS symptoms may
present months after the onset of pulmonary symptoms [30].
Paragonimus species can also migrate to subcutaneous tissue
and cause subcutaneous nodules in up to 20% of patients with
P. westermani infection [26, 28, 31]. Our patients 1 and 2 had
migratory skin nodules; to our knowledge, this has not pre-
viously been reported for cases of P. kellicotti infection.
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physical examinations [31]. Others may have nonspecific find-
ings such as rales or rhonchi in the chest (present in up to
28% of patients) [27]. Laboratory abnormalities include leuko-
cytosis (24%–33% of patients) [26–28] and eosinophilia (62%–
66% of patients) [27, 28]. A similar percentage of North Amer-
icans with paragonimiasis had eosinophilia (6 [75%] of 8 pa-
tients). Radiographic abnormalities are common among pa-
tients with paragonimiasis in Asia, with 52% of patients hav-
ing air-space consolidation and 37% of patients having pleural
effusions [32]. All 10 North American patients demonstrated
abnormal chest radiographic findings, including “nonspecific
linear streaking” [20], pneumothorax (1 patient) [18], pleural
effusion (6 patients) [18, 19, 21, 22], and consolidation or an
infiltrate (7 patients) [1, 18, 19, 21–23].
It is difficult to make a direct parasitological diagnosis of par-
agonimiasis by microscopy. Although the presence of ova in ex-
pectorated sputum is specific, the sensitivity of this test is low
(28%–38%). Repeat sputum examinations may increase the
sensitivity of this test [28]. Stool examination is also insensitive
[31], and ova are not usually found in pleural fluid [28, 31].
Pleural fluids commonly have low glucose levels (!10 mg/dL)
and high total protein levels (13 g/dL) [28]. Pleural fluid white
blood cell counts are often 11000 cells/mm3 [28, 33].
Serological testing is useful for establishing the diagnosis of
paragonimiasis. The Centers for Disease Control and Preven-
tion perform an ELISA that is highly sensitive (96%) and spe-
cific (99%) for P. westermani [34]. The sensitivity of this test
for serum samples from patients with other species of Para-
gonimus infection, including P. kellicotti, is unknown. This may
explain the negative test result from patient 3. Despite his neg-
ative test result, patient 3’s history, clinical presentation, and
response to praziquantel therapy were consistent with the di-
agnosis of paragonimiasis. Patients 1 and 2 in our study both
had an ELISA that was positive for P. westermani.
The current recommended treatment for paragonimiasis is
praziquantel 25 mg/kg given orally 3 times daily for 2 days.
Cure rates of 195% have been reported [35]. All 3 of our
patients had excellent clinical responses to praziquantel, with
improved symptoms and resolution of eosinophilia.
In summary, although paragonimiasis is considered to be
rare among humans in North America, we cared for 3 patients
with proven or probable paragonimiasis at a medical center
during an 18-month period. All 3 patients had recently ingested
raw crayfish from rivers in Missouri. It is likely that other cases
of paragonimiasis have been recognized and treated in this
region, but not reported. More troubling, it is also likely that
some patients with paragonimiasis have been misdiagnosed
and, therefore, were not properly treated. This infection is eas-
ily avoidable; public health education messages should warn
people not to ingest uncooked crayfish. Our local cases show
that alcohol use, boating, and the consumption of raw cray-
fish can be a dangerous mixture. Health warnings might have
the greatest impact if they were posted or distributed at camp-
grounds and canoe rental businesses in the lower midwest.
Physicians should consider the possibility of paragonimiasis
among patients who present with cough, fever, hemoptysis,
and eosinophilia.
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